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Background: The transition between acute care and community care represents a vulnerable period in health care
delivery. The vulnerability of this period has been attributed to changes to patients’ medication regimens during
hospitalization, failure to reconcile discrepancies between admission and discharge and the burdening of patients/
families to take over care responsibilities at discharge and to relay important information to the primary care
physician. Electronic communication platforms can provide an immediate link between acute care and community
care physicians (and other community providers), designed to ensure consistent information transfer. This study
examines whether a transfer-of-care (TOC) communication tool is efficacious and cost-effective for reducing hospital
readmission, adverse events and adverse drug events as well as reducing death.
Methods: A randomized controlled trial conducted on the Medical Teaching Unit of a Canadian tertiary care centre
will evaluate the efficacy and cost-effectiveness of a TOC communication tool. Medical in-patients admitted to the
unit will be considered for this study. Data will be collected upon admission, and a total of 1400 patients will be
randomized. The control group’s acute care stay will be summarized using a traditional dictated summary, while
the intervention group will have a summary generated using the TOC communication tool. The primary outcome
will be a composite, at 3 months, of death or readmission to any Alberta acute-care hospital. Secondary outcomes
will be the occurrence of post-discharge adverse events and adverse drug events at 1 month post discharge.
Patients with adverse outcomes will have their cases reviewed by two Royal College certified internists or
College-certified family physicians, blinded to patients’ group assignments, to determine the type, severity,
preventability and ameliorability of all detected adverse outcomes. An accompanying economic evaluation will
assess the cost per life saved, cost per readmission avoided and cost per QALY gained with the TOC
communication tool compared to traditional dictation summaries.
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Discussion: This paper outlines the study protocol for a randomized controlled trial evaluating an electronic
transfer-of-care communication tool, with sufficient statistical power to assess the impact of the tool on the
significant outcomes of post-discharge death or readmission. The study findings will inform health systems around
the world on the potential benefits of such tools, and the value for money associated with their widespread
implementation.
Trial registration: ClinicalTrials.gov NCT01402609.
Keywords: Medical informatics, Care transitions, Electronic health records, Randomized controlled trials, Hospital
dischargeBackground
The transition between acute care and community care
represents one of the most vulnerable periods in health
care delivery, particularly as the complexity of inpatient
populations increases. The vulnerability of this period
has been attributed to three main factors. First, changes
to patients’ medication regimens during hospitalization
are numerous, yet failure to reconcile discrepancies be-
tween admission and discharge is frequent [1]. Second,
the patient/family is required to take over care responsi-
bilities at discharge and must often personally relay im-
portant information to the primary care physician [1].
This can be particularly challenging if the TOC informa-
tion is poorly communicated, presented too rapidly, if
instructions are verbal only, or if the patient struggles
with health literacy [1-3]. Finally, crucial information is
often not transferred between acute care physicians and
community physicians [1].
Information about the hospitalization (such as medica-
tion changes, patient diagnoses, interventions, diagnostic
findings, and necessary follow-up) is commonly trans-
ferred to the community care physician through a sum-
mary of the patient’s acute care stay that is faxed or
mailed. Deficits with respect to timeliness and/or com-
plete failure to transmit are widespread [1,4]. At the first
post-discharge appointment, this summary is unavailable
to the community care physicians up to 75% of the time
[1,5-7]. This negatively impacts the continuity of care
provided to many patients [1,7]. When summaries are
received, inconsistent content and inaccuracies are com-
mon [1,4]. Acute care physicians, whether medical or
surgical, often neglect to include diagnostic findings,
treatment/hospital course, discharge medications, pend-
ing tests results, and whether the patient and family
received counseling [7].
Computer-enabled TOC communications have poten-
tial to avert such problems. These communication tools,
operating on electronic health record or web-based plat-
forms can provide an immediate link between acute
care and primary care physicians, and interfaces can
be designed to ensure consistent information transfer.
In addition, physicians in both settings have expressedpreference for electronic discharge documents over
hand written/dictated summaries with respect to clar-
ity, comprehensiveness, and positive impacts on con-
tinuity of care [8-11].
Kripalani and collegues [4] published a systematic re-
view examining the prevalence of discharge communica-
tion deficits and looked broadly at all types of
interventions that target those deficits. Very few of the
interventions reviewed by Kripilani et al. involved signifi-
cant contributions from electronic medical record data
to construct the discharge summary, and none used the
internet to transmit information. However, the publica-
tions years considered spanned 1977 to 2005.
In recent years, original studies [9-20] have emerged
assessing the efficacy of computer enabled TOC commu-
nication compared to traditional summaries. In the con-
text of a rapidly growing literature on electronic medical
records and telehealth interventions, our team systemat-
ically reviewed the literature and identified 12 controlled
studies assessing the efficacy of computer-enabled TOC
communication tools [14]. The findings in the literature
globally indicate that compared to traditional TOC
summaries, computer-enabled TOC communications of
various types appear promising, particularly with re-
spect to improving timeliness of discharge summary de-
livery, and satisfaction among physicians and patients/
families. There are also some positive impacts on overall
patient management and continuity of care. However,
only four of these studies reported the effects of such
tools on the notable clinical endpoints of hospital re-
admission, post-discharge mortality, and adverse events
[14], and in doing so, none had sufficient statistical
power to assess these endpoints. As a result, only one
study [15] in our review demonstrated a reduction in
readmission to hospital within 12 months due to the im-
plementation of a web-based TOC communication plat-
form. Our published systematic review identified a need
for a well-designed, sufficiently powered study evaluating
relevant clinical outcomes associated with an electronic-
ally based TOC tool. Given the growing demand and
monetary investments associated with these tools, such a
study would have implications on a global scale.
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University of Calgary, in Alberta, Canada is an interdis-
ciplinary research and innovation program focused on
health system safety and quality (see www.w21c.org).
The W21C team, working collaboratively with Alberta
Health Services, the provincial health authority, under-
took iterative consultation with multiple clinical stake-
holders as well as patients and family, and developed an
electronic communication TOC tool. The tool was built
off of the already functioning electronic platform called
Sunrise Clinical Manager (SCM) that physicians use to
manage inpatient orders and to access patient medical
records, diagnostic imaging and laboratory results. An
initial pilot test of the tool involving 100 actual patient
transfers of care summaries from an adult internal medi-
cine ward to the community was performed on the
Medical Teaching Unit (MTU) affiliated with the W21C.
This pilot study involved detailed assessments of usabil-
ity issues, provider and patient satisfaction, completeness
and timeliness of the discharge summaries. The informa-
tion generated from this pilot led to the refinement of
the tool to the extent that it satisfied the needs of acute
care physicians, primary care physicians, and patients.
The refined tool will be made available for use by physi-
cians and medical students on the MTU and used for
this study.
On this backdrop of iterative tool development and
pilot work, a protocol for a randomized controlled trial
to more definitely test the efficacy of the TOC commu-
nication tool was developed. With funding from the
Canadian Institutes of Health Research, the RCT will as-
sess the efficacy of the TOC communication tool for re-
ducing the endpoint of death or hospital readmission at
3 months. Secondary objectives are: i) to assess the im-
pact of the tool on the occurrence of post-discharge ad-
verse events and adverse drug events; ii) to evaluate the
cost-effectiveness of the tool.
Methods
Setting
The study will be conducted on the Medical Teaching
Unit (MTU) of a Canadian tertiary Medical Center. The
MTU is a general internal medicine unit that provides
care to adults who have non-surgical medical problems
that necessitate hospitalization. The typical patient on
the team has multi-system disease and/or complex
symptom presentations that require detailed diagnostic
evaluation and/or inpatient therapies. Patients typically
have multiple comorbid illnesses and complicated medi-
cation profiles that require careful scrutiny and review at
time of discharge. Pilot work on the MTU revealed that
approximately one in four patients discharged from the
unit were readmitted within a 3 month period (i.e., 51
out of 219 cases reviewed in our pilot work).The MTU consists of three physician teams working
in parallel on multiple hospital wards throughout the
hospital. The three teams have indistinguishable clinical
expertise and consist of similarly-trained attending staff
physicians and rotating medical residents and students.
They care for similar patient populations and work in
the same environment, with assistance from the shared
nurse discharge coordinator. The teams are already
undertaking a diligent process of pre-acute care dis-
charge preparation (i.e., prior to implementation of the
TOC communication tool) in which attempts are made
to prepare communication materials for community pro-
viders. This is therefore a highly appropriate setting for
the study of a TOC tool, because the patient population
is at high risk for readmission, and one for whom
enhanced clinical communication produced by the TOC
communication tool can be evaluated on a backdrop of
already diligent discharge preparation practices.
Participants
All patients admitted to the MTU will be considered for
this study. Patients will be excluded if the patient and/or
family member declines consent; is under 18 years of
age; cannot provide contact information; and/or family
member lacks English proficiency and the team cannot
communicate with them; has a research burden (en-
rolled in 2 other studies); is admitted under or has their
acute care transferred to a clinical service other than the
MTU; is not an Alberta resident; was previously enrolled
in the study; is being discharged to hospice care; is
transferred to another Hospital (“Rapid Transport”); is
incoherent; or dies in hospital.
Written information about the study will be provided to
patients before obtaining informed consent. The study has
been approved by the Conjoint Health Research Ethics
Board at the University of Calgary (# 23469) and registered
at ClinicalTrials.gov (NCT01402609).
Study design
Patients will be randomly assigned to discharge from
acute care with the TOC tool (intervention group) versus
usual care (control group). The intervention will consist
of patient’s acute-care stay summaries being generated
with the use of the computer-enabled communication
tool. The tool provides a standardized template for com-
municating all relevant clinical information on patients
who are leaving hospital, is immediately available at time
of leaving and is accessible through the web by
community-based providers (family physicians, specia-
lists, home care nurses, and community pharmacists).
Figure 1, Figure 2, Figure 3 show screen shots taken
from various points in the TOC tool. This is in contrast
to current summaries that the control group will receive
under usual care (control group). Usual care involves
Figure 1 The introduction page for a test patient from the seamless transfer-of-care tool.
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dictated/transcribed summaries. This usual care typically
involves paper-based handwritten summaries with sub-
sequent provision of a dictated summary produced some
time after the patient leaves hospital, with unpredictable
success and timing of delivery and with unstructured
and sometimes haphazard content.
Upon admission to the MTU, the research team
will approach the patient for consent and will collect
baseline data including socio-demographic informa-
tion, co-morbidities (using the Charlson co-morbidity
measurement method [21]), and current health status
using the Health Utilities Index (HUI) [22,23]. A
chart review will be conducted on each patient. This
information will be collected on a secure, web-based
program that was developed by the University of Cal-
gary’s new Clinical Trial Research Unit (CRU). The
CRU has also generated a web-based method for ran-
dom allocation of patients to intervention versus con-
trol. Randomization will be requested from the
investigators, and will be entirely concealed from theresearchers. Randomization will be performed within
48 hours of patients leaving hospital rather than at
the time of them leaving due to the nature of the
MTU in which, decisions about when patients can
leave often occur without much notice and residents
often do not have time to complete a summary im-
mediately given competing clinical activities. To en-
sure that patients will be leaving the hospital with
either a copy of the completed summary produced
by the TOC tool or, conversely, a hand written note
for the control group, the summaries will be started
by providers some time prior to the patient leaving.
Figure 4 provides a summary of this process.
Study measures
Baseline measures
Patient sociodemographic characteristics At the first
study visit (baseline assessment) the patients will be pre-
sented with a brief sociodemographic questionnaire.
Items included are age, sex, level of education, employ-
ment status, and admission diagnosis.
Figure 2 The medication details off of a test patient from the seamless transfer-of-care tool.
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Information about the patients’ admission to the MTU,
comorbidities, medication changes, alcohol and sub-
stance abuse, and living arrangements will be collected
from patients’ hospital charts prior to their discharge
from hospital.
Outcome measures
The primary outcome of interest for the clinical trial is the
composite, at 3 months, of death or readmission to any
Alberta acute-care hospital. Secondary outcomes of inter-
est are the occurrence of post-discharge adverse events
and adverse drug events at 1 month post discharge. Pa-
tient health status, meanwhile, will be assessed at baseline,
1 and 3 months using the Health Utilities Index [22,23].
The elements of our composite primary outcome (i.e.,
death or readmission) are identified for study because
these are recognized to be major events that we areultimately trying to prevent through safer health care.
The 3 month time frame is felt to be most relevant, be-
cause it is short enough to potentially relate to discharge
communications, but also long enough after discharge to
permit some events to accrue. The primary outcomes of
interest will be assessed through existing linkages to
hospitalization data from the Alberta Health Services
Health Outcomes Group (for readmission to acute care
hospitals), and to the Alberta Vital Statistics for post-
discharge mortality. Such an approach to post-discharge
outcome ascertainment avoids the shortcoming of unre-
liable patient self-report on readmission, and the poten-
tial challenges associated with determining vital status of
patients that we are unable to reach by telephone.
The outcomes of post-discharge adverse events and
adverse drug events will be determined using the
method described by Forster and colleagues [24,25]. At
1 month post discharge, a trained investigator, blinded to
Figure 3 Existing health issues off of a test patient from the seamless transfer-of-care tool.
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survey using a survey tool that takes approximately 15
minutes to complete to determine the post-hospital
course for all consenting patients. This will allow us to
determine readmission/physician visits/emergency de-
partment visits, and whether an adverse event or adverse
drug event occurred. Two Royal College certified inter-
nists or College-certified family physicians, also blinded
to patients’ group assignments, will independently rate
the type, severity, preventability and ameliorability of all
possible adverse events. Adverse events will be classified
into the following types: 1. adverse drug events; 2.
procedure-related injury; 3. nosocomial infection, 4.
care-related fall, 5. therapeutic error, 6. diagnostic error
or 7. other types. Further information on this validated
multi-step method is available elsewhere [24,25].
Health utilities index
Patient health status and health-related quality of life
(HRQOL) will be measured using the Health UtilitiesIndex Mark 3 (HUI3) [22,23]. HUI3 assesses a full range
of health among diverse groups of patients and reflects
co-morbidities, and has been widely used in every major
Statistics Canada population health survey in Canada
since 1990 [23]. Additionally, the HUI3 can be converted
to a utility score; the required input to calculate the cost
per QALY gained. During the 1 and 3 months post-
hospital stay, a trained investigator, blinded to patient
group assignments, will administer a telephone version
that takes approximately 15 minutes to complete.
Economic evaluation
The economic evaluation will have two primary out-
comes: the cost per life and the cost per hospital re-
admission avoided using the TOC communication tool
compared to traditional dictation. A secondary outcome
will be the cost per QALY gained using the web-based
TOC communication tool compared to traditional dicta-
tion. All outcomes (clinical events and utility scores) will
be assessed through the clinical arm of the RCT. The
Figure 4 Flowchart of the protocol for the seamless transfer-of-care study.
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from corporate financial data including the cost of devel-
opment, implementation, integration and training. The
cost of dictation (for type-written dictated discharge
summaries the usual mode of discharge summary cre-
ation in the absence of this discharge tool) will be esti-
mated based on physician time, transcription costs, anddissemination costs. Costs of on-going care will be esti-
mated from administrative data including ER visits,
physician visits and hospitalization. Total costs of care
and outcome events will be calculated for each arm of
the trial. For each objective, the cost difference between
arms will be divided by the benefit difference to result in
cost to benefit ratio.
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enrollment
As previously mentioned, a recent pilot done by the
W21C team demonstrated that patients discharged from
the MTU had a 23% probability of readmission to Cal-
gary hospitals within 3 months (51 out of 219 discharged
patients assessed in a pilot chart review). From this, we
estimate an absolute event rate of 25% in the control
group for the composite of death or readmission, and
have designed our study to detect an approximately 25%
relative reduction (i.e., a 6.25% absolute reduction) in
the readmission rate in the intervention group. There-
fore, using p1=0.25, and p2=0.1875, with alpha=0.05 and
beta=0.80 in our two-tailed sample size calculation, we
will require 686 patients per group. Our research plan is
to enroll 700 patients per group, allowing for a safety
margin for attrition. Each of the three teams usually pro-
cesses an average of 2 to 4 discharges per day. As such,
we anticipate that we will complete enrollment of 1400
subjects within an 18 month period and full assessment
of outcomes and follow-up surveys in a 2 year period.
For the secondary endpoints of post-hospital adverse
events and adverse drug events, we will have adequate
statistical power given that these adverse events are
known to occur frequently, in approximately one quarter
of patients discharged from acute-care hospitals [1,2].
The sample size is appropriate to assess patient health
status measured by HUI3 to compare two independent
means for a parallel trial design, 697 patients in each
group are needed to detect a clinically important differ-
ence (CID) in HUI3 overall score of 0.03 (SD=0.20).
Data analysis
The baseline characteristics (age, sex, principal diagnosis
categories, and comorbididy conditions) of intervention
and control subjects will be recorded and compared be-
tween groups using Chi-square tests or Fisher Exact
tests where appropriate. We will also use t-tests for
comparison of continuous variables. The same statistical
tests will be used to compare outcomes between the two
groups. Chi-square and Fisher exact tests will be used to
compare the frequency of dichotomous outcomes (i.e.,
death or readmission, adverse events, adverse drug
events). For the subset of patients who are readmitted in
the two groups, we will use t-tests to compare the time-
to-readmission of patients and patient health status
(HUI3 overall scores) in the intervention versus control
groups. A Kaplan-Meier analysis with log-rank test will
be used to perform a time-to-event analysis in all sub-
jects. For the economic evaluation, total costs of care
and outcome events will be calculated for each arm of
the trial. For each outcome, the cost difference between
arms will be divided by the benefit difference to result in
cost to benefit ratio.The analysis will be performed by intention-to-treat.
Patients will be analyzed in the group to which they
were randomized, even if the summary of their hospital
stay is generated using a communication method that
differs from their group assignment. CONSORT report-
ing guidelines (http://www.consort-statement.org) will
be used to diligently track and report treatment cross-
overs and losses to follow-up through a progressive
flow-chart. We will work diligently during the course of
the study to limit the frequency of such occurrences.
This will be achieved by a system of clear labeling of pa-
tient charts immediately after random allocation so that
the care team will be aware of the assigned summary of
care communication method. Research associates
affiliated with the study will also be present among the
clinical care team daily to reinforce the issue of compli-
ance to patient assignments.
Discussion
This paper outlines the study protocol for a sufficiently
powered randomized controlled trial, incorporating an
economic evaluation, looking at an electronic communi-
cation TOC tool developed through the partnership be-
tween Alberta Health Services, the University of Calgary,
and the W21C. Since the tool is designed to transfer
standardized, appropriate and accurate information in a
timely manner, the study will provide evidence on how
efficacious the tool will be at reducing hospital readmis-
sion, death after discharge, adverse events, adverse drug
events, improving patients’ health status and its cost-
effectiveness.
Randomized controlled trials (RCT) are regarded as
the gold standard for clinical research assessing the effi-
cacy of an intervention. Unlike many of the pre-post
studies identified in our previously-mentioned system-
atic review, the present RCT is a parallel design that
provides for an unbiased estimate of the effects of the
intervention. Another key aspect of the present RCT is
that allocation will be concealed.
Despite the obvious benefits of the parallel design with
randomization, there are also some challenges. Most
notably, our study design involves trade-offs between the
benefits of randomizing individual patients versus the
potential contamination of providers’ discharge practices
when they are dealing with both the intervention and
control group patients. A cluster-randomized design was
considered as an approach for dealing with the latter
concern. Cluster randomization has become popular in
medical studies in the past two decades [26-28]. If a
cluster-randomized trial design had been chosen, each
individual medical team would have been allocated to
either intervention or control, instead of individually al-
locating patients. While using a cluster-randomization
design can diminish costs and lower experimental
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discharge template by a provider to guide a dictated
summary in the usual care group), this method is less
efficient than individual-randomized trials as members
within a cluster tend to be more similar to one another
than randomly allocated participants [26-28]. To com-
pensate for the inefficiency of cluster-randomization, a
larger sample size is required to meet statistical signifi-
cance [28]. Furthermore, there is potential for there to
be between-service differences that would affect the in-
ternal validity of the study and the comparability of the
intervention and control groups. Balancing these com-
peting concerns, and in dialogue with funding agency
peer reviewers, we opted for the randomization of indi-
vidual patients to intervention and control to maximize
the benefits of comparability between groups.
Other challenges inherent to this study relate to
acute-care physician preference and familiarity with one
method for generating hospital summaries over the
other, and community-care physician software incom-
patibilities. In a few instances, acute-care physicians
may have or will develop a preference of using one sys-
tem over the other. This may result in a given physician
not following the patient’s assigned randomization,
resulting in the exclusion of the patient and a loss of
that randomization. We expect to minimize this prob-
lem by continually educating and informing the phy-
sicians of the study and the importance to adhere to
the randomization assignments, as well as maintaining
a strong presence throughout the MTU. More so,
some community-care physicians may experience ac-
cessibility issues to the TOC summaries electronic
records due to software program incompatibilities.
While we foresee this as a current problem, we hope
that this study will encourage the implementation of
compatible programs.
This study will be one of the first to have sufficient
statistical power to definitively examine the important
clinical outcomes of readmission, mortality and adverse
events after patients leave an acute-care facility using an
electronically-based TOC communication tool. The tool
that we are assessing has the potential to ameliorate a
vulnerable period in health care, thus enhancing patient
safety and quality of care through better communication
at times of transfers of care. The tool has already been
pilot tested in our jurisdiction, and through this RCT is
being evaluated more broadly. This study will inform
our own and other health systems globally on the poten-
tial efficacy and cost implications of such electronic
communication tools. Given the widespread demand
and growing investments into such electronic tools (e.g.,
President Obama’s $19.2 billion investment into elec-
tronic health information technology [29]) the implica-
tions of such research are truly far reaching.Abbreviations
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